This Turnaround Story Has Massive Upside Potential in 2020

Medical Facilities Corporation (TSX:DR) has 100% potential upside, but patient investors should wait before buying shares.

| More on:
edit U-turn

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

It hasn’t been a good 2019 for Medical Facilities (TSX:DR).

The company’s shares tanked twice this year on bad earnings — most recently when the company released its second-quarter results on August 8. Issues with the company’s latest quarterly numbers included a 5.2% decrease in revenue versus the same quarter last year, a US$29.5 million non-cash impairment charge related to one of its hospitals, and earnings fell off a cliff. The company had a payout ratio of 74.3% in the second quarter of 2018. The payout ratio surged to 179% in its most recent quarter.

The stock, which was already struggling because of weak first-quarter numbers, tanked again. It fell all the way from the $12.50 range to settle in the $6-$7-per-share range. The good news is, shares have rallied recently and recently surpassed $8 each on strong volume.

I personally believe the company is a great turnaround story, and shares could march higher in 2020. But investors shouldn’t crowd into the name quite yet for a very important reason.

The bull case

In theory, Medical Facilities should have a pretty steady business. The company owns five specialty surgical hospitals as well as eight ambulatory service centres, all located in the United States. These centres deal with specific procedures that the doctors who work at the facilities specialize in, which offers plenty of predictable revenue. At least they should, anyway. So, what happened in the most recent quarter?

Perhaps the biggest issue has been the company’s investment in Unity Medical and Surgical Hospital in Mishawaka, Indiana. It posted revenues of US$3.1 million less than the same quarter last year due to changes in the case mix or payer mix. Management is confident a focus on partnering with new physicians in this market will improve operating results.

Medical Facilities also made a one-time payment of US$1.1 million to sever a contract in its most recent quarter.

Once we exclude all these one-time items, the quarter wasn’t so bad. The company also sees results picking up over the last half of the year, since many people will want to use their medical insurance benefits before they lose them. And investors should be reminded that there’s still a new ambulatory service centre on track to open in 2020, which should boost the bottom line.

How safe is the dividend?

If I were on the board of directors, I’d push for Medical Facilities to cut its generous dividend. The yield, which checks in at a whopping 14% today, is simply too high. The company should cut it in half and use the proceeds to ramp up its acquisition program.

The good news for income investors who already own the stock is, there’s no guarantee of a dividend cut. The company’s payout ratio over the last year is under 100% and should remain there if results start to improve. The company also has a strong cash position that can be used to pay distributions in the case of continued weak results, although that can’t be maintained indefinitely.

Wait to buy

Overall, I think Medical Facilities has decent turnaround potential. After a couple of decent quarters, shares could easily be 25-50% higher. Yet I think investors should wait to buy. Why?

The company is a prime candidate for tax-loss-selling season, which will really pick up momentum in November and December. Shares will be under pressure, as disappointed dividend investors look at their statements and see a stock that’s down 50% for the year.

It’s better to buy in January, when we won’t have tax-loss selling pushing down shares. The stock has massive upside potential — I don’t see any reason why it can’t trade at $15 again — but I don’t think that’ll happen until 2020.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Nelson Smith owns shares of MEDICAL FACILITIES CORP. The Motley Fool owns shares of MEDICAL FACILITIES CORP.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »